Analyst Recommendations

25.15 0.25(1.00%)07/03/2024
Genmab (GMAB)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy15
Outperform1
Underweight1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades